Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Altering certain molecular interactions could yield new strategies for treating prostate cancer

Research led by Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has discovered that altering certain molecular interactions could yield new strategies for treating prostate cancer and related diseases.

6 Oct 2023

New drugs have increased survival rates for men with metastatic prostate cancer

Survival rates for men with metastatic prostate cancer have increased by an average of six months, something which coincides with the gradual introduction of 'dual treatment' since 2016.

3 Oct 2023

Genomic testing rates soar for Black patients with prostate cancer after introduction of precision medicine navigators

The presence of a clinical navigator to act as a liaison between people with prostate cancer and the health care system greatly increases the likelihood that patients, especially Black patients, will receive advanced testing that can help predict the severity of their disease and guide treatment, a new study suggests.

3 Oct 2023

Shorter course of radiation therapy just as effective for intermediate risk prostate cancer, study shows

People with intermediate risk, localized prostate cancer can be treated as effectively using fewer and higher doses of radiation therapy delivered over five treatment sessions as they can with lower doses delivered over several weeks, a new phase III randomized trial suggests.

3 Oct 2023

Challenges and opportunities for better lung cancer care for the elderly

A new editorial paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 17, entitled, "Promising trends in lung cancer care, but are we overlooking the majority?"

28 Sep 2023

Scientists identify mutations in 11 genes associated with aggressive forms of prostate cancer

An international research team led by scientists in the Center for Genetic Epidemiology at the Keck School of Medicine of USC and USC Norris Comprehensive Cancer Center has singled out mutations in 11 genes that are associated with aggressive forms of prostate cancer.

21 Sep 2023

Unlocking the power of mRNA vaccines: From COVID-19 to cancer and beyond

A comprehensive review in Signal Transduction and Targeted Therapy delves into the versatility and effectiveness of mRNA vaccines, from their game-changing role in COVID-19 to potential applications in cancer and rare diseases. Despite drawbacks like stability and high immunogenicity, advancements in vaccine technology have poised mRNA platforms as a robust tool for both preventive and therapeutic interventions.

21 Sep 2023

Study offers new insight into immune cells critical to successful vaccination against SARS-CoV-2

A study has revealed new details about a key population of immune system cells critical to successful vaccination against the pandemic virus, SARS-CoV-2.

21 Sep 2023

New treatment approach effectively treats the most aggressive forms of prostate cancer

Researchers at the University of Chicago Medicine Comprehensive Cancer Center established "proof-of-concept" for a new treatment approach that was able to effectively treat the most aggressive forms of prostate cancer. The treatment showed complete tumor control and long-lasting survival without side effects in a mouse model of advanced prostate cancer.

19 Sep 2023

Turning fish waste into cancer fighters: How abalone viscera peptides could be the next big thing in medicine

Researchers explore the potential of bioactive peptides from abalone fish viscera for their antimicrobial and anticancer properties. The study finds promising activity against various bacterial and fungal strains, as well as cytotoxic effects on prostate cancer cells.

17 Sep 2023

AACR Cancer Progress Report provides latest statistics on cancer research and treatment

Today, the American Association for Cancer Research (AACR) released the 13th edition of its annual Cancer Progress Report, which chronicles how basic, translational, and clinical cancer research and cancer-related population sciences-;primarily supported by federal investments in the National Institutes of Health (NIH) and the National Cancer Institute (NCI)-;remain vitally important to improving health and saving lives.

13 Sep 2023

Unified and concentrated lung cancer advocacy program results in 25% increase in research funding

A unified and concentrated lung cancer advocacy program in the United States resulted in a 25 percent increase in funding to a U.S.-based lung cancer research program, according to a presentation given today at the International Association for the Study of Lung Cancer 2023 World Conference on Lung Cancer in Singapore.

12 Sep 2023

PI3K pathway rewiring drives prostate cancer growth

Experts in cell signaling at the Babraham Institute have identified how prostate cancer cells achieve cell growth free from the usual growth cues and regulators.

11 Sep 2023

Is there an association between the COVID-19 pandemic and cancer incidence?

The COVID-19 pandemic influenced cancer incidence.

8 Sep 2023

Rising tide of early-onset cancers: Study predicts alarming increase by 2030

An international study published in BMJ Oncology analyzes the Global Burden of Disease 2019 dataset to explore the rising incidence and mortality rates of early-onset cancers (ages 14-49) worldwide. The study highlights varying cancer burdens by gender and region, identifies lifestyle and environmental risk factors, and predicts a significant increase in early-onset cancer rates by 2030.

7 Sep 2023

New consensus statement provides guidance for use of 177Lu-PSMA radionuclide therapy in mCRPC patients

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has issued a new consensus statement to provide standardized guidance for the selection and management of metastatic castrate-resistant prostate cancer (mCRPC) patients being treated with 177Lu-PSMA radionuclide therapy.

5 Sep 2023

Free online tool could potentially mitigate financial toxicity for some prostate cancer patients

A free online tool could potentially save some prostate cancer patients more than $9,000 in out-of-pocket drug costs, a new study finds.

5 Sep 2023

New cancer therapy shows promise in mouse models, slows or reverses tumor growth

A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division.

4 Sep 2023

Men with sneaky testosterone physiology have worse prostate cancer outcomes, study finds

First-of-its-kind study on 266 men found 20% have higher levels of the hormone in the vessels surrounding the prostate.

4 Sep 2023

Amgen to discuss application for LUMAKRAS® (sotorasib) for the treatment of KRAS G12C-positive NSCLC at FDA advisory committee meeting

Amgen today announced the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) will review data supporting the supplemental New Drug Application (sNDA) for the full approval of LUMAKRAS® (sotorasib) for adults with previously treated locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer (NSCLC) at a meeting on Oct. 5, 2023.

From AMGEN 1 Sep 2023

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Altering certain molecular interactions could yield new strategies for treating prostate cancer

New drugs have increased survival rates for men with metastatic prostate cancer

Genomic testing rates soar for Black patients with prostate cancer after introduction of precision medicine navigators

Shorter course of radiation therapy just as effective for intermediate risk prostate cancer, study shows

Challenges and opportunities for better lung cancer care for the elderly

Scientists identify mutations in 11 genes associated with aggressive forms of prostate cancer

Unlocking the power of mRNA vaccines: From COVID-19 to cancer and beyond

Study offers new insight into immune cells critical to successful vaccination against SARS-CoV-2

New treatment approach effectively treats the most aggressive forms of prostate cancer

Turning fish waste into cancer fighters: How abalone viscera peptides could be the next big thing in medicine

AACR Cancer Progress Report provides latest statistics on cancer research and treatment

Unified and concentrated lung cancer advocacy program results in 25% increase in research funding

PI3K pathway rewiring drives prostate cancer growth

Is there an association between the COVID-19 pandemic and cancer incidence?

Rising tide of early-onset cancers: Study predicts alarming increase by 2030

New consensus statement provides guidance for use of 177Lu-PSMA radionuclide therapy in mCRPC patients

Free online tool could potentially mitigate financial toxicity for some prostate cancer patients

New cancer therapy shows promise in mouse models, slows or reverses tumor growth

Men with sneaky testosterone physiology have worse prostate cancer outcomes, study finds

Amgen to discuss application for LUMAKRAS® (sotorasib) for the treatment of KRAS G12C-positive NSCLC at FDA advisory committee meeting

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in